1887

Chapter 8 : Mycoplasmas

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Mycoplasmas, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap08-1.gif /docserver/preview/fulltext/10.1128/9781555817961/9781555811891_Chap08-2.gif

Abstract:

Mycoplasmas and ureaplasmas represent a complex and unique group of microorganisms that has previously been ignored by most diagnostic laboratories. Bacteria commonly referred to as mycoplasmas (fungus form) are included within the class Mollicutes (soft skin), which comprises four orders, five families, eight genera, and over 150 known species. Diagnostic kits for the detection and preliminary characterization of mycoplasmas are generally similar, consisting of strips with wells containing specific dried or lyophilized substrates and inhibitors. Descriptions of some of the most widely used commercial mycoplasma growth media, corresponding diagnostic kits, and their manufacturers are provided. The availability of frozen or freezedried mycoplasma media from commercial sources facilitates such transport or subculture as may be needed on an infrequent basis for low-volume laboratories that do not offer complete diagnostic service for mycoplasmas. There are no automated instruments or procedures available to detect mycoplasmas in clinical specimens. Recent data obtained using the Bact/ALERT instrument have again demonstrated the inability of automated blood culture systems to flag blood cultures containing mycoplasmas. The culture-based procedures and products described in this chapter are suitable for performance in a high-complexity hospital-based general microbiology laboratory or reference laboratory. The availability of complete diagnostic kits, similar to those now sold in Europe and some other areas may further increase the likelihood that hospital-based microbiology laboratories will begin offering diagnostic services for mycoplasmas, provided the kits can be proven to be accurate when compared directly with standard methods.

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8

Key Concept Ranking

Lower Respiratory Tract Infections
0.42932257
Antimicrobial Susceptibility Testing
0.42006356
0.42932257
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Immuno (Meridian Diagnostics). The Meridian Immuno is a qualitative, membrane-based EIA that can be performed in 10 min or less to detect the presence of IgM antibody directed against . A positive test is indicated by the development of a blue color in both of the upper reaction ports. Photograph courtesy of Lanier Thacker.

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

IgG and IgM Antibody Test System (Remel Laboratories). The Remel IgG and IgM Antibody Test System is a qualitative, membrane-based EIA that can be performed in 10 min or less to detect IgG and IgM antibodies against . A positive test is indicated by the presence of a visible purple dot in the test well. Photograph courtesy of Lanier Thacker.

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Etest technique for determining in vitro susceptibilities for . Shown is a Remel SP4 agar plate and quinupristin-dalfopristin Etest demonstrating in vitro susceptibility testing of at low power (a) and high power (b). MIC = 0.5 μg/ml.

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817961.chap8
1. Abele-Horn, M.,, C. Blendinger,, C. Becher,, P. Emmerling,, and G. Ruckdeschel. 1996. Evaluation of commercial kits for quantitative identification and tests on antibiotic susceptibility of genital mycoplasmas. Zentbl. Bakteriol. 284:540549.
2. Alexander, T. S.,, L. D. Gray,, J. A. Kraft,, D. S. Leland,, M. T. Nikaido,, and D. H. Willis. 1996. Performance of Meridian ImmunoCard Mycoplasma test in a multicenter clinical trial. J. Clin. Microbiol. 34:11801183.
3. Aubert, G.,, B. Pozzetto,, O. G. Gaudin,, J. Hafid,, A. D. Mbida,, and A. Ros. 1992. Evaluation of five commercial tests: complement fixation, microparticle agglutination, indirect immunofluorescence, enzyme-linked immunosorbent assay and latex agglutination, in comparison to immunoblotting for Mycoplasma pneumoniae serology. Ann. Biol. Clin. 50:593597.
4. Barker, C. E.,, M. Sillis,, and T. G. Wreghitt. 1990. Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with μ-capture ELISA and indirect immunofluorescence. J. Clin. Pathol. 43:163165.
5. Bébéar, C.,, and J. A. Robertson,. 1996. Determination of minimal inhibitory concentration, p. 189197. In J. G. Tully, and S. Razin (ed.), Molecular and Diagnostic Procedures in Mycoplasmology. Academic Press, New York, N.Y..
6. Broitman, N. L.,, C. M. Floyd,, C. A. Johnson,, L. M. de la Maza,, and E. Peterson. 1992. Comparison of commercially available media for detection and isolation of Ureaplasma urealyticum and Mycoplasma hominis. J. Clin. Microbiol. 30:13351337.
7. Cavicchini, S.,, M. R. Biffi,, A. Brezzi,, and E. Alessi. 1989. Mycoplasma hominis and Ureaplasma urealyticum: comparison of media for isolation and prevalence among patients with nongonococcal nonchlamydial genital infections. G. Ital. Dermatol. Venereol. 124:321324.
8. Choppa, P. C.,, A. Vodjani,, C. Tagle,, R. Andrin,, and L. Magtoto. 1998. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol. Cell. Probes 12:301308.
9. Cimolai, N.,, and A. C. H. Cheong. 1996. An assessment of a new diagnostic indirect enzyme immunoassay for the detection of anti-Mycoplasma pneumoniae IgM. Clin. Microbiol. Infect. Dis. 105:205209.
10. Clegg, A.,, M. Passey,, M. Yoannes,, and A. Michael. 1997. High rates of genital mycoplasma infections in the highlands of Papua New Guinea determined both by culture and by a commercial detection kit. J. Clin. Microbiol. 35:197200.
11. Dosa, E.,, E. Nagy,, W. Falk,, I. Szoke,, and U. Ballies. 1999. Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum. J. Antimicrob. Chemother. 43:575578.
12. Echevarria, J. M.,, P. Leon,, P. Balfagon,, J. A. Lopez,, and M. V. Fernandez. 1990. Diagnosis of Mycoplasma pneumoniae infection by microparticle agglutination and antibody-capture enzyme-immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 9:217220.
13. Fedorko, D. P.,, D. D. Emery,, S. M. Franklin,, and D. D. Congdon. 1995. Evaluation of a rapid enzyme immunoassay system for serologic diagnosis of Mycoplasma pneumoniae infection. Diagn. Microbiol. Infect. Dis. 23:8588.
14. Gerstenecker, B.,, and E. Jacobs,. 1993. Development of a capture-ELISA for the specific detection of Mycoplasma pneumoniae in patient’s material, p. 195205. In I. Kahane, and A. Adoni (ed.), Rapid Diagnosis of Mycoplasmas. Plenum Press, New York, N.Y.
15. Granström, M.,, T. Holme,, A. M. Sjögren,, A. Örtqvist,, and M. Kalin. 1994. The role of IgA determination by ELISA in the early serodiagnosis of Mycoplasma pneumoniae infection, in relation to IgG and μ-capture IgM methods. J. Med. Microbiol. 40:288292.
16. Karppelin, M.,, K. Hakkarainen,, M. Kleemola,, and A. Miettinen. 1993. Comparison of three serological methods for diagnosing Mycoplasma pneumoniae infection. J. Clin. Pathol. 46:11201123.
17. Kenny, G. E.,, G. G. Kaiser,, M. K. Cooney,, and H. M. Foy 1990. Diagnosis of Mycoplasma pneumoniae pneumonia: sensitivities and specificities of serology with lipid antigen and isolation of the organism on soy peptone medium for identification of infections. J. Clin. Microbiol. 28:20872093.
18. Lieberman, D.,, D. Lieberman,, S. Horowitz,, O. Horovitz,, F. Schlaeffer,, and A. Porath. 1995. Microparticle agglutination versus antibody-capture enzyme immunoassay for diagnosis of community-acquired Mycoplasma pneumoniae pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 14:577584.
19. Lind, K. 1982. Serological cross-reaction between Mycoplasma genitalium and M. pneumoniae. Lancet ii:11581159.
20. Marston, B. J.,, J. F. Plouffe,, T. M. File,, B. A. Hackman,, S.-J. Salstrom,, H. B. Lipman,, M. S. Kolczak,, R. F. Breiman, and the Community Based Pneumonia Study Group. 1997. Incidence of community-acquired pneumonia requiring hospitalization. Arch. Intern. Med. 157:17091718.
21. Masover, G. K.,, and F. A. Becker,. 1996 Detection of mycoplasmas by DNA staining and fluorescent antibody methodology, p. 419429. In J. G. Tully, and S. Razin (ed.), Molecular and Diagnostic Procedures in Mycoplasmology. Academic Press, New York, N.Y..
22. Matas, L.,, J. Domínguez,, F. De Ory,, N. García,, N. Gali,, P. J. Cardona,, A. Hernández,, C. Rodrigo,, and V. Ausina. 1998. Evaluation of Meridian ImmunoCard mycoplasma test for the detection of Mycoplasma pneumoniae-specific IgM in pediatric patients. Scand. J. Infect. Dis. 30:289293.
23. Phillips, L. E.,, K. H. Goodrich,, R. M. Turner,, and S. Faro. 1986. Isolation of Mycoplasma species and Ureaplasma urealyticum from obstetrical and gynecological patients by using commercially available medium formulations. J. Clin. Microbiol. 24:377379.
24. Pratt, B., 1990 Automatic blood culture systems: detection of Mycoplasma hominis in SPS-containing media, p. 778781. In G. Staneck,, G. H. Cassell,, J. G. Tully,, and R. F. Whitcomb (ed.), Recent Advances in Mycoplasmology. Gustav Fischer Verlag, Stuttgart, Germany.
25. Razin, S. 1994. DNA probes and PCR in diagnosis of mycoplasma infections. Mol. Cell. Probes 8:497511.
26. Renaudin, H.,, and C. Bébéar. 1990. Evaluation des systemes Mycoplasma PLUS et SIR Mycoplasma pour la detection quantitative et l’etude de la sensibilite aux antibiotiques des mycoplasmes genitaux. Pathol. Biol. 38:431435.
27. Samra, Z.,, and R. Gadba. 1993. Diagnosis of Mycoplasma pneumoniae infection by specific IgM antibodies using a new capture-enzyme immunoassay. Eur. J. Epidemiol. 9:9799.
28. Shepard, M. C., 1983 Culture media for ureaplasmas, p. 137146. In S. Razin, and J. G. Tully (ed.), Methods in Mycoplasmology, vol. 1. Academic Press, Inc., New York, N.Y..
29. Shepard, M. C.,, and C. D. Lunceford. 1978. Serological typing of Ureaplasma urealyticum isolates from urethritis patients by an agar growth inhibition method. J. Clin. Microbiol. 8:566574.
30. Sillis, M. 1990. The limitation of IgM assays in the serological diagnosis of Mycoplasma pneumoniae infection. J. Med. Microbiol. 33:253258.
31. Sillis, M. 1993. Genital mycoplasmas revisited—an evaluation of a new culture medium. Br. J. Biomed. Sci. 50:8991.
32. Talkington, D. F.,, W. L. Thacker,, D. W. Keller,, and J. S. Jensen. 1998. Diagnosis of Mycoplasma pneumoniae infection in autopsy and open-lung biopsy tissues by nested PCR. J. Clin. Microbiol. 36:11511153.
33. Thacker, W. L.,, and D. F. Talkington. 1995. Comparison of two rapid commercial tests with complement fixation for serologic diagnosis of Mycoplasma pneumoniae infections. J. Clin. Microbiol. 33:12121214.
34. Thacker, W. L.,, and D. F. Talkington. 2000. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin. Diagn. Lab. Immunol. 7:778780.
35. Tully, J. G.,, D. L. Rose,, R. F. Whitcomb,, and R. P. Wenzel. 1979. Enhanced isolation of Mycoplasma pneumoniae from throat washings with a newly modified culture medium. J. Infect. Dis. 139:478482.
36. Waites, K. B.,, G. H. Cassell,, L. B. Duffy,, and K. B. Searcey. 1995 Isolation of Ureaplasma urealyticum from low birthweight infants. J. Pediatr. 126:502.
37. Waites, K. B.,, D. M. Crabb,, L. B. Duffy,, and G. H. Cassell. 1997. Evaluation of the Etest for detection of tetracycline resistance in Mycoplasma hominis. Diagn. Microbiol. Infect. Dis. 27:117122.
38. Waites, K. B.,, K. C. Canupp,, and G. E. Kenny. 1999. In vitro susceptibilities of Mycoplasma hominis to moxifloxacin determined by Etest and agar dilution. Drugs 58(Suppl. 2):406407.
39. Waites, K. B.,, and D. Taylor-Robinson,. 1999 Mycoplasma and Ureaplasma, p. 782794. In P. R. Murray,, E. J. Baron,, M. A. Pfaller,, F. C. Tenover,, and R. H. Yolken (ed.), Manual of Clinical Microbiology, 7th ed. American Society for Microbiology, Washington, D.C..
39.a. Waites, K. B.,, and K. C. Canupp. Evaluation of the BacT/ALERT system for detection of Mycoplasma hominis in simulated blood cultures. J. Clin. Microbiol, in press.
40. Wood, J. C.,, R. M. Lu,, E. M. Peterson,, and L. M. de la Maza. 1985. Evaluation of Mycotrim-GU for isolation of Mycoplasma species and Ureaplasma urealyticum. J. Clin. Microbiol. 22:789792.
41. Wreghitt, T. G.,, and M. Sillis. 1985. A μ-capture ELISA for detecting Mycoplasma pneumoniae IgM: comparison with indirect immunofluorescence and indirect ELISAs. J. Hyg. 94:217227.

Tables

Generic image for table
TABLE 1

Mycoplasma detection and susceptibility testing kits produced in France and sold in various countries

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8
Generic image for table
TABLE 2

Major test kits for detection of serum antibodies to sold in the United States

Citation: Waites K, Talkington D, Bébéar C. 2002. Mycoplasmas, p 201-224. In Truant A (ed), Manual of Commercial Methods in Clinical Microbiology. ASM Press, Washington, DC. doi: 10.1128/9781555817961.ch8

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error